# BU Clinical HIV/AIDS Research Training Program

> **NIH NIH T32** · BOSTON MEDICAL CENTER · 2020 · $223,690

## Abstract

Project Summary/Abstract:
 The Boston University Clinical HIV/AIDS Research Training (BU-CHART) Program provides rigorous
postgraduate training to physicians and other health scientists to enable them to conduct high-quality, ethical
HIV/AIDS research focused on disadvantaged populations. BU-CHART will provide specific training in
research methods of relevance to study co-morbidities, adherence, substance abuse and transmission of HIV
infection. A particular focus will be training in research ethics, a particular strength of Boston University. The
Program Site is Boston University Medical Center (BUMC), comprised of the Boston University School of
Medicine (BUSM), Boston University School of Public Health (BUSPH), and Boston Medical Center (BMC), the
“safety net" hospital for the city of Boston. The program also has well-established field sites in South Africa,
Uganda, and Zambia.
 BUMC investigators have a strong record of sponsored research in HIV epidemiology, HIV/hepatitis C
co-infection, HIV and alcohol abuse, adherence, prevention, international HIV research, and HIV interactions
with tuberculosis. The BU-CHART Program Director, Dr. Robert Horsburgh, has been the Director or Co-
director of the program since its inception in 2003. BU-CHART will be administratively based in the Section of
Infectious Diseases (ID), Department of Medicine, BUSM. One Global and three Domestic trainees each year
will enter a structured program that includes an introductory series of didactic lectures in HIV/AIDS, classroom
work and a mentored thesis leading to the MSc or PhD degree in Epidemiology, ethics coursework and
mentoring and a series of Clinical Research seminars as part of the Boston University CREST Program. Each
trainee will have a mentoring team comprised of a Senior Mentor, a Project-specific Mentor, and an Ethical
Mentor. The candidate’s research will focus on one of four specific subject areas where BU has particular
strengths: Opportunistic Diseases, Adherence and Natural History, Substance Use and Transmission. The
primary goal of BU-CHART is to enable trainees to become independent investigators in HIV/AIDS research
with a special focus and expertise in research in disadvantaged populations.

## Key facts

- **NIH application ID:** 9950974
- **Project number:** 5T32AI052074-15
- **Recipient organization:** BOSTON MEDICAL CENTER
- **Principal Investigator:** Benjamin P. Linas
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $223,690
- **Award type:** 5
- **Project period:** 2003-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9950974

## Citation

> US National Institutes of Health, RePORTER application 9950974, BU Clinical HIV/AIDS Research Training Program (5T32AI052074-15). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9950974. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*